These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23306969)

  • 1. Identification of potential inhibitors of H5N1 influenza A virus neuraminidase by ligand-based virtual screening approach.
    Karthick V; Ramanathan K; Shanthi V; Rajasekaran R
    Cell Biochem Biophys; 2013 Jul; 66(3):657-69. PubMed ID: 23306969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic behavior of avian influenza A virus neuraminidase subtype H5N1 in complex with oseltamivir, zanamivir, peramivir, and their phosphonate analogues.
    Udommaneethanakit T; Rungrotmongkol T; Bren U; Frecer V; Stanislav M
    J Chem Inf Model; 2009 Oct; 49(10):2323-32. PubMed ID: 19780597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on "Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV)".
    Rungrotmongkol T; Malaisree M; Udommaneethanakit T; Hannongbua S
    Biophys Chem; 2009 Apr; 141(1):131-2; author reply 133. PubMed ID: 19231807
    [No Abstract]   [Full Text] [Related]  

  • 4. Virtual screening for oseltamivir-resistant a (H5N1) influenza neuraminidase from traditional Chinese medicine database: a combined molecular docking with molecular dynamics approach.
    Karthick V; Ramanathan K
    Springerplus; 2013 Dec; 2(1):115. PubMed ID: 23638404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding mechanism of H5N1 influenza virus neuraminidase with ligands and its implication for drug design.
    Gong K; Li L; Wang JF; Cheng F; Wei DQ; Chou KC
    Med Chem; 2009 May; 5(3):242-9. PubMed ID: 19442214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of multi-binding-site inhibitors, ligand efficiency, and consensus screening of avian influenza H5N1 wild-type neuraminidase and of the oseltamivir-resistant H274Y variant.
    García-Sosa AT; Sild S; Maran U
    J Chem Inf Model; 2008 Oct; 48(10):2074-80. PubMed ID: 18847186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.
    Xie Y; Xu D; Huang B; Ma X; Qi W; Shi F; Liu X; Zhang Y; Xu W
    J Med Chem; 2014 Oct; 57(20):8445-58. PubMed ID: 25255388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase.
    An J; Lee DC; Law AH; Yang CL; Poon LL; Lau AS; Jones SJ
    J Med Chem; 2009 May; 52(9):2667-72. PubMed ID: 19419201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational design of novel, high-affinity neuraminidase inhibitors for H5N1 avian influenza virus.
    Park JW; Jo WH
    Eur J Med Chem; 2010 Feb; 45(2):536-41. PubMed ID: 19914748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtual screening pipeline and ligand modelling for H5N1 neuraminidase.
    D'Ursi P; Chiappori F; Merelli I; Cozzi P; Rovida E; Milanesi L
    Biochem Biophys Res Commun; 2009 Jun; 383(4):445-9. PubMed ID: 19371724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Computational Model for Docking of Noncompetitive Neuraminidase Inhibitors and Probing their Binding Interactions with Neuraminidase of Influenza Virus H5N1.
    Chintakrindi AS; Martis EA; Gohil DJ; Kothari ST; Chowdhary AS; Coutinho EC; Kanyalkar MA
    Curr Comput Aided Drug Des; 2016; 12(4):272-281. PubMed ID: 27412704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of oseltamivir analogs inhibiting neuraminidase of avian influenza virus H5N1.
    Rungrotmongkol T; Frecer V; De-Eknamkul W; Hannongbua S; Miertus S
    Antiviral Res; 2009 Apr; 82(1):51-8. PubMed ID: 19428595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacophore-Based Virtual Screening for Identification of Novel Neuraminidase Inhibitors and Verification of Inhibitory Activity by Molecular Docking.
    Batool S; Mushtaq G; Kamal W; Kamal MA
    Med Chem; 2016; 12(1):63-73. PubMed ID: 26152143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics simulation of oseltamivir resistance in neuraminidase of avian influenza H5N1 virus.
    Shu M; Lin Z; Zhang Y; Wu Y; Mei H; Jiang Y
    J Mol Model; 2011 Mar; 17(3):587-92. PubMed ID: 20517627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.
    Du QS; Wang SQ; Chou KC
    Biochem Biophys Res Commun; 2007 Oct; 362(2):525-31. PubMed ID: 17707775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of Potent Neuraminidase Inhibitors Using a Combination of Pharmacophore-Based Virtual Screening and Molecular Simulation Approach.
    K R; V S
    Appl Biochem Biotechnol; 2018 Apr; 184(4):1421-1440. PubMed ID: 29063410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuraminidase inhibitor R-125489--a promising drug for treating influenza virus: steered molecular dynamics approach.
    Mai BK; Li MS
    Biochem Biophys Res Commun; 2011 Jul; 410(3):688-91. PubMed ID: 21693105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of novel oseltamivir derivatives as potent neuraminidase inhibitors.
    Wang Z; Cheng LP; Zhang XH; Pang W; Li L; Zhao JL
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5429-5435. PubMed ID: 29141777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of drug resistance of chicken influenza A virus (H5N1) from homology-modeled 3D structures of neuraminidases.
    Wang SQ; Du QS; Chou KC
    Biochem Biophys Res Commun; 2007 Mar; 354(3):634-40. PubMed ID: 17266937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery andsynthesis of novel benzoylhydrazone neuraminidase inhibitors.
    Fu SK; Cheng LP
    Bioorg Med Chem Lett; 2024 Jun; 105():129743. PubMed ID: 38608962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.